Importance of the stem cell microenvironment for ophthalmological cell-based therapy

被引:26
|
作者
Wan, Peng-Xia [1 ]
Wang, Bo-Wen [2 ]
Wang, Zhi-Chong [2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China
来源
WORLD JOURNAL OF STEM CELLS | 2015年 / 7卷 / 02期
关键词
Microenvironment; Niche; Stem cell; Cell-based therapy; Ocular diseases; Ophthalmology;
D O I
10.4252/wjsc.v7.i2.448
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cell therapy is a promising treatment for diseases that are caused by cell degeneration or death. The cells for clinical transplantation are usually obtained by culturing healthy allogeneic or exogenous tissue in vitro. However, for diseases of the eye, obtaining the adequate number of cells for clinical transplantation is difficult due to the small size of tissue donors and the frequent needs of long-term amplification of cells in vitro, which results in low cell viability after transplantation. In addition, the transplanted cells often develop fibrosis or degrade and have very low survival. Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPS) are also promising candidates for cell therapy. Unfortunately, the differentiation of ESCs can bring immune rejection, tumorigenicity and undesired differentiated cells, limiting its clinical application. Although iPS cells can avoid the risk of immune rejection caused by ES cell differentiation post-transplantation, the low conversion rate, the risk of tumor formation and the potentially unpredictable biological changes that could occur through genetic manipulation hinder its clinical application. Thus, the desired clinical effect of cell therapy is impaired by these factors. Recent research findings recognize that the reason for low survival of the implanted cells not only depends on the seeded cells, but also on the cell microenvironment, which determines the cell survival, proliferation and even reverse differentiation. When used for cell therapy, the transplanted cells need a specific three-dimensional structure to anchor and specific extra cellular matrix components in addition to relevant cytokine signaling to transfer the required information to support their growth. These structures present in the matrix in which the stem cells reside are known as the stem cell microenvironment. The microenvironment interaction with the stem cells provides the necessary homeostasis for cell maintenance and growth. A large number of studies suggest that to explore how to reconstruct the stem cell microenvironment and strengthen its combination with the transplanted cells are key steps to successful cell therapy. In this review, we will describe the interactions of the stem cell microenvironment with the stem cells, discuss the importance of the stem cell microenvironment for cell-based therapy in ocular diseases, and introduce the progress of stem cell-based therapy for ocular diseases.
引用
收藏
页码:448 / 460
页数:13
相关论文
共 50 条
  • [1] Stem Cell-Based Cell Therapy for Glomerulonephritis
    Jin, Meiling
    Xie, Yuansheng
    Li, Qinggang
    Chen, Xiangmei
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [2] Importance of Stem Cell Migration and Angiogenesis Study for Regenerative Cell-based Therapy: A Review
    Aziz, Nur S.
    Yusop, Norhayati
    Ahmad, Azlina
    CURRENT STEM CELL RESEARCH & THERAPY, 2020, 15 (03) : 284 - 299
  • [3] Stem cell-based photodynamic therapy
    Tej B. Shrestha
    Gwi M. Seo
    Matthew T. Basel
    Mausam Kalita
    Hongwang Wang
    David Villanueva
    Marla Pyle
    Sivasai Balivada
    Raja Shekar Rachakatla
    Heather Shinogle
    Prem S. Thapa
    David Moore
    Deryl L. Troyer
    Stefan H. Bossmann
    Photochemical & Photobiological Sciences, 2012, 11 : 1251 - 1258
  • [4] Mesenchymal Stem Cell-Based Therapy
    Mundra, Vaibhav
    Gerling, Ivan C.
    Mahato, Ram I.
    MOLECULAR PHARMACEUTICS, 2013, 10 (01) : 77 - 89
  • [5] Prospects for stem cell-based therapy
    Daley, George Q.
    Scadden, David T.
    CELL, 2008, 132 (04) : 544 - 548
  • [6] Stem cell-based photodynamic therapy
    Shrestha, Tej B.
    Seo, Gwi M.
    Basel, Matthew T.
    Kalita, Mausam
    Wang, Hongwang
    Villanueva, David
    Pyle, Marla
    Balivada, Sivasai
    Rachakatla, Raja Shekar
    Shinogle, Heather
    Thapa, Prem S.
    Moore, David
    Troyer, Deryl L.
    Bossmann, Stefan H.
    PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2012, 11 (07) : 1251 - 1258
  • [7] Stem Cell-Based Disease Modeling and Cell Therapy
    Bai, Xiaowen
    CELLS, 2020, 9 (10)
  • [8] Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell-based therapy
    Azizi, Ramyar
    Aghebati-Maleki, Leili
    Nouri, Mohammad
    Marofi, Faroogh
    Negargar, Sohrab
    Yousefi, Mehdi
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 333 - 343
  • [9] The role of microenvironment in stem cell-based regeneration of intervertebral disc
    Chu, Genglei
    Zhang, Weidong
    Han, Feng
    Li, Kexin
    Liu, Chengyuan
    Wei, Qiang
    Wang, Huan
    Liu, Yijie
    Han, Fengxuan
    Li, Bin
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [10] Stem cell-based cell therapy for neuroprotection in stroke: A review
    Rikhtegar, Reza
    Yousefi, Mehdi
    Dolati, Sanam
    Kasmaei, Hosein Delavar
    Charsouei, Saeid
    Nouri, Mohammad
    Shakouri, Seyed Kazem
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) : 8849 - 8862